VEGFA and age-related macular degeneration: Unadjusted Cox models demonstrated a non-significantly increased risk of progression to exudative AMD and of anti-VEGF injection among patients on lipid-lowering medications, as well as among all subgroups with the exception of patients on fibrates and hydrophilic statins (S2 Fig).